Patent Classification

Drug Delivery System, Solubilization

1. Use of oligomers and polymers for drug solubilization, stabilization, and delivery
    
2. Hybrid system for solubilizing pharmaceutically active substances in polymer matrices
    
3. Peptides as solubilizing excipients for transforming growth factor beta proteins
    
4. Water soluble nanoparticles of hydrophilic and hydrophobic active materials and an apparatus and method for their production
    
5. Formulation solubilizing water-insoluble agents and preparation method thereof
    
6. N,N-dinitramide salts as solubilizing agents for biologically active agents
    
7. Composition for solubilizing salicylic acid
    
8. Water-soluble compositions of bioactive lipophilic compounds
    
9. Solubilizers containing alk(en)yl oligoglycosides and polyol components, and methods of solubilizing using the same
    
10. Compositions containing therapeutically active components having enhanced solubility
     
11. Solvent system for enhancing solubility
    
    
12. Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles
    
    
13. Pharmaceutical composition comprising cyclosporin
    
    
14. Pharmaceutical composition comprising cyclosporin
     
    
15. C₇ -C₁₂ Diol & Diol alkoxylates as coupling agents for surfactant formulations
     
    
16. Method of solubilizing itraconazole
     
    
17. Water-soluble compositions of bioactive lipophilic compounds
     
    
18. Solubility parameter based drug delivery system and method for altering drug saturation concentration
     
    
19. Alkyl or olefinic endcapped polyalkylene oxide solubilizer
     
    
20. Method and compositions for solubilization and stabilization of polypeptides, especially proteins
     
    
21. Aqueous composition containing solubilized or dispersed oil-soluble substance

Drug Delivery System, Solution/Supersaturated Solution

1. Retinoid solutions and formulations made therefrom
    
2. Stable bicarbonate-based solution in a single container
    
3. Preparation of aqueous clear solution dosage forms with bile acids
    
4. Preparation of aqueous clear solution dosage forms with bile acids
    
5. Liquid pharmaceutical composition
    
6. Pharmaceutical solutions of modafinil compounds
    
7. Homogeneous cyclosporin-containing solution
    
8. Aqueous pharmaceutical composition containing moxifloxacin or salts thereof
    
9. IFN-.beta. liquid formulations
    
10. Stabilized aspirin compositions and method of preparation for oral and topical use
     
11. Ionic aqueous composition containing levomenthol
     
12. Soluble contraceptive liquid formulation
     
13. Method for preparing aqueous phytosphingosine solution
    
    
14. Solvent system for enhancing solubility
    
    
15. Pharmaceutical composition comprising cyclosporin
    
    
16. Thickened aqueous surfactant solutions
     
    
17. Aqueous drink composition comprising ibuprofen
     
    
18. Stable calcitriol solution for packaging into vials
     
    
19. Solution containing nicotine
     
    
20. Aqueous solution of t-PA
     
    
21. Stabilizing solutions for proteins and peptides
     
    
22. Thickened hydrolyte isotonic beverage
     
    
23. Cosolvent formulations
     
    
24. Oxybutynin formulations and method of use
     
    
25. Cyanamide aqueous solution
     
    
26. Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same
     
    
27. Pharmaceutical formulations of taxanes
     
    
28. Solubility parameter based drug delivery system and method for altering drug saturation concentration
     
    
29. Stable aqueous solution having high concentrations of calcium and phosphate ions and solid complex
     
    
30. Supersaturated ascorbic acid solutions
     
    
31. Compositions and method for treating migraine
     
    
32. Solubilisation aids

Drug Delivery System, Sponge

1. Hemostatic sponge based on collagen

Drug Delivery System, Spray, Nasal/Dermal/Others

1. Nasal spray steroid formulation and method
    
2. Nasal spray for treating streptococcal infections
    
3. Topical spray for burn treatment and anti-infection
    
4. Spray composition
    
5. Nasal spray compositions
    
6. Film forming compositions for topical use and delivery of active ingredients
    
7. Sprayable analgesic composition and method of use
    
8. Nasal spray for decongesting nasal passages
    
9. Topical spray for burn treatment and anti-infection
    
10. Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa
    
    
11. Antihistamine sprays and ointments for relief of delayed contact dermatitis

Drug Delivery System, Sublingual

1. Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
    
2. Human chorionic gonadotropin (hCG) formulations for facilitating weight loss and body contouring
    
3. Sublingual compositions comprising thymosin fraction 5 and methods for administration thereof
    
4. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
    
5. Sublingual oral dosage form
    
6. Buccal and sublingual administration of physostigmine
    
   
7. Sublingual buccal effervescent

Drug Delivery System, Sunscreen/Tanning

1. Sunscreen safety and efficacy enhancement
    
2. Therapeutic soap product with UV protection
    
3. Topical acne vulgaris medication with a sunscreen
    
4. Sulfur-modified zinc oxide
    
5. Topical acne vulgairs medication with a sunscreen
    
6. Stabilized sunscreen composition having a particulate inorganic sunscreen
    
7. Sunscreen composition
    
8. Sunscreen formulations containing nucleic acids
    
9. Sunscreen compositions
    
10. Composition containing a peptide and a pigment and the use thereof in darkening the skin
     
11. Plant-based non-toxic sunscreen products
     
12. Sunscreen compositions
     
13. Tyrosinase inhibitors from plants
     
14. Sun-protection formulations active against herpes simplex viruses
     
15. Enhanced SPF sunscreen (sprayable) formulations comprising interpolymers of PVP/dimethiconylacrylate/polycarbamyl/polyglycol ester
     
16. Method for preparing ultraviolet radiation-absorbing compositions
    
    
17. Sunscreen with disappearing color indicator
     
    
18. Delivery system for inorganic sunscreens
     
    
19. Method, apparatus, and composition for automatically coating the human body
     
    
20. Composition for protecting skin from damaging effects of ultraviolet light
     
    
21. Ultraviolet-screening zinc oxide excellent in transparency and composition containing the same
     
    
22. Sunscreen having disappearing color
     
    
23. Sunscreen formulation with avobenzone and method for stabilizing sunscreen formulation which contains avobenzone
     
    
24. Powder coated with sparingly soluble ultraviolet absorber
     
    
25. Delivery system for suncare products
     
    
26. Sunscreen applicator system
     
    
27. High SPF sunscreen formulations
     
    
28. High efficiency skin protection formulation with sunscreen agents and antioxidants
     
    
29. Substantive topical composition
     
    
30. Use of emu oil for stimulating skin and hair growth
     
    
31. Sunscreen compositions
     
    
32. Sunscreen cosmetic composition

Drug Delivery System, Suppository/Rectal

1. Urogenital or anorectal, transmucosal vaccine delivery system
    
2. Suppository of retaining in lower region of rectum
    
3. Percutaneously applicable preparation and suppository containing an antidementia medicament
    
4. Suppositories
    
5. Controlled, phased-release suppository and its method of production
    
   
6. Suppository containing an antidementia medicament
    
   
7. JM216 formulations
    
   
8. Long-lasting composition for rectal administration
    
   
9. Vaginal suppository vaccine for urogenital infections
    
   
10. Pharmaceutical suppository composites for fever and influenza and method of producing the composites
     
    
11. Unit galenical formulation for local hormonotherapy of vaginal dryness
     
    
12. Method of the manufacture of suppositories

Drug Delivery System, Supramolecular Complex

1. Orally deliverable supramolecular complex

Drug Delivery System, Surfactant

1. Surfactants that mimic the glycocalyx
    
2. Aqueous surfactant compositions of monoalkyl phosphate ester salts and amphoteric surfactants
    
3. C₇ -C₁₂ Diol & Diol alkoxylates as coupling agents for surfactant formulations

Drug Delivery System, Suspension/Dispersion

1. Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
    
2. Aqueous suspension of nanoscale drug particles from supercritical fluid processing
    
3. Pharmaceutical compositions for bioactive peptide agents
    
4. Stabilized dispersions comprising excipient surface-modified organic nanoparticles and medicament particles
    
5. Oral pharmaceutical suspension of Cefdinir crystal
    
6. Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
    
7. Stabilized bioactive preparations and method of use
    
8. Thickener for high-surfactant aqueous systems
    
9. Microprecipitation method for preparing submicron suspensions
    
10. Composition comprising ubiquinone
     
11. Polyol/oil suspensions for the sustained release of proteins
     
12. Method for preparing submicron suspensions with polymorph control
     
13. Stable non-dihydrate azithromycin oral suspensions
     
14. Liquid dispersion polymer compositions, their preparation and their use
     
15. Drinkable ibuprofen pharmaceutical suspension
     
16. Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
     
17. Preparing aqueous polymer dispersions
     
18. Process for preparing an oral suspension of a pharmaceutical substance
     
19. Stable particle in liquid formulations
     
20. Preparation of injectable suspensions having improved injectability
     
21. Method for forming an aqueous flocculated suspension
     
22. Microprecipitation method for preparing submicron suspensions
     
23. Flocculated suspension of megestrol acetate
     
24. Process for preparing a crystal suspension
     
25. Excipient for the lyophilization of aqueous suspensions of microparticles
     
26. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
     
27. Nonaqueous fluorinated drug delivery suspensions
     
28. Hydrocarbon gels as suspending and dispersing agents and products
     
29. Suspension of sparingly water-soluble acidic drug
     
    
30. Taste masked liquid suspensions
     
    
31. Pharmaceutical suspension comprising nevirapine hemihydrate
     
    
32. Stabilized ascorbic acid, composition, and method of use
     
    
33. Fluidized polymer suspensions of cationic polysaccharides in polyols and use thereof in personal care compositions
     
    
34. Process and composition for therapeutic cisplatin (CDDP)
     
    
35. Sterilization process for pharmaceutical suspensions
     
    
36. DASC compositions, process for preparing same and suspensions containing same
     
    
37. Decongestant/antihistaminic compositions
     
    
38. Ultra-fine microcrystalline cellulose compositions and process
     
    
39. Flocculated suspension of megestrol acetate
     
    
40. Fluid suspension of polysaccharides for personal care and household applications
     
    
41. Enhancement of guar solution stability

Drug Delivery System, Sweetener, Artificial

1. Method of improving sweetness delivery of sucralose
    
2. Anhydrous lactitol crystals, a product containing the same and a process for the preparation thereof as well as use thereof
    
3. Method of improving sweetness delivery of sucralose

Drug Delivery System, Syrup

1. Stabilized antihistamine syrup
    
2. Stabilized antihistamine syrup

Drug Delivery System, Tablet/Caplet/Compressed Dosage Form

1. Vaginal tablets comprising misoprostol and methods of making and using the same
    
2. Direct compressible trehalose solids
    
3. Solid dosage form of wetted heparin
    
4. Tablet composition with a prolonged release of tamsulosin
    
5. Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance, and respective processes of producing same and a cup-shaped envelope of same
    
6. Fast dissolving tablet and method of preparing the same
    
7. System for delaying drug delivery up to seven hours
    
8. Stable tablet formulation
    
9. Pharmaceutical safety dosage forms
    
10. Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms
     
11. Orally disintegrable tablets
     
12. Modified release oral dosage form using co-polymer of polyvinyl acetate
     
13. Tabletting process
     
14. Process for producing solid dosage forms
     
15. Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
     
16. Ondansetron orally disintegrating tablets
     
17. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
     
18. Sustained release formulations containing acetaminophen and tramadol
     
19. Modified calcium phosphate excipient
     
20. Simethicone containing tablet composition and method
     
21. Multilayer dosage forms containing NSAIDs and triptans
     
22. Pharmaceutical tablets having height greater than width
     
23. Directly compressible tricalcium phosphate
     
24. Methods for targeted drug delivery
     
25. Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
     
26. Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
     
27. Process for producing an oral sustained-release preparation of fasudil hydrochloride
     
28. Rapidly disintegrating methylcellulose tablets
     
29. Processes for the preparation of oral dosage formulations of modafinil
     
30. Directly compressible formulations of azithromycin
     
31. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
     
32. Controlled absorption diltiazem pharmaceutical formulation
     
33. Fast disintegrating tablet
     
34. Fenofibrate pharmaceutical composition having high bioavailabilty
     
35. Soft chewable tablets
     
36. Method for preparing solid dosage form of desmopressin
     
37. Second release phase formulation
     
38. Bitterness-reduced intrabuccally quick disintegrating tablets and method for reducing bitterness
     
39. Process for the preparation of directly compressible α-mannitol
     
40. Once a day antihistamine and decongestant formulation
     
41. Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same
     
42. Paroxetine controlled release compositions
     
43. Water soluble powders and tablets
     
44. Storage stable thyroxine active drug formulations and methods for their production
     
45. Pharmaceutical excipient having improved compressibility
     
46. Chrono delivery formulations and method of use thereof
     
47. Stable pharmaceutical compositions without a stabilizer
     
48. Directly compressible raw material for tablets
     
49. Once-a-day controlled release sulfonylurea formulation
     
50. Dosage forms and methods for oral delivery of progesterone
     
51. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
     
52. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
     
53. Production of a directly compressible tabletting aid
     
54. Microcrystalline cellulose cushioning granules
     
55. Stabilization of solid thyroid drug formulations
     
56. Directly compressible high load acetaminophen formulations
     
57. Rapidly expanding starches with altered crystalline structure
     
58. Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems
     
59. Powdered/microfibrillated cellulose
     
60. Technical field (quick disintegrating tablet)
     
61. Substituted benzimidazole dosage forms and method of using same
     
62. Process for the preparation of direct tabletting formulations and aids
     
63. Amoxicillin and potassium clavulanate dosage form
     
64. Process for preparing non-hygroscopic sodium valproate composition
     
65. Modified release pharmaceutical formulation comprising amoxycillin
     
66. Pharmaceutical excipient having improved compressibility
     
67. Fast dissolving tablet
     
68. Orodispersible tablets containing fexofenadine
     
69. Method for increasing the active loading of compressible composition forms
     
70. Use of an acrylic type polymer as disintegrating agent
     
71. Exactly divisible tablet
     
72. Filler binder for tablets
     
73. Aqueous dispersion suitable for the production of coatings and binders for solid oral drugs
     
74. Fenofibrate pharmaceutical composition having high bioavailability
     
75. Instant granules and process for their formulation
     
76. Bioadhesive progressive hydration tablets
     
77. Dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications
     
78. Solid dose forms containing bismuth
     
79. Oral pulsed dose drug delivery system
     
80. Dispersible macrolide compounds and method for production thereof
     
81. Highly compressible ethylcellulose for tableting
     
82. Simple tablet compression using gelatin
     
83. Pharmaceutical excipient having improved compressibility
     
84. Compressed nitroglycerin tablet and its method of manufacture
     
85. Binder-free compacted forms of 1,3-dihalo-5,5-dimethylhydantoins
     
86. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
     
87. Process for manufacturing bite-dispersion tablets
     
88. Pharmaceutical excipient having improved compressibility
     
89. Chargeable pharmaceutical tablets
    
    
90. Gellan gum tablet coating
    
    
91. Directly compressible high load acetaminophen formulations
    
    
92. Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process
    
    
93. Self-destructing, controlled release peroral drug delivery system
    
    
94. Pharmaceutical excipient having improved compressibility
    
    
95. Dividable tablet and press-through pack 
    
    
96. Abuse resistant tablets
     
    
97. Quickly disintegratable compression-molded materials and process for producing the same
     
    
98. Apparatus and method for tablet fabrication
     
    
99. Pulverulent sorbitol and its process of preparation
     
    
100. Directly compressible, ultra fine acetaminophen compositions and process for producing same
      
     
101. Bioadhesive progressive hydration tablets and methods of making and using the same
      
     
102. Sustained release matrix for high-dose insoluble drugs
      
     
103. Dissolution of triprolidine hydrochloride
      
     
104. Directly compressible high load acetaminophen formulations
      
     
105. Pharmaceutical excipient having improved compressibility
      
     
106. Solid, non-deliquescent formulations of sodium valproate
      
     
107. Impeding the extraction of active ingredients out of tablets
      
     
108. Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient
      
     
109. Stabilized thyroxine medications
      
     
110. Solid pharmaceutical composition comprising an excipient capable of binding water
      
     
111. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
      
     
112. Once daily analgesic tablet
      
     
113. Pharmaceutical tablet designed for easier breaking
      
     
114. Low-dosed steroid tablets that contain gallic acid ester as an antioxidant, process for production, and use
      
     
115. Healthful dissolvable oral tablets, and mini-bars
      
     
116. Free-flowable directly compressible starch as binder, disintegrant and filler for compression tablets and hard gelatine capsules
      
     
117. Tablet containing a coated core
      
     
118. Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
      
     
119. Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
      
     
120. Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
      
     
121. Stable compositions containing N-propargyl-1-aminoindan
      
     
122. Cisapride sustained release
      
     
123. Direct compression metformin hydrochloride tablets
      
     
124. Solid compositions containing polyethylene oxide and an active ingredient
      
     
125. Paroxetine tablets and process to prepare them
      
     
126. Cisapride mini-tablet formulations
      
     
127. Multiparticulate tablet disintegrating in less than 40 seconds in the mouth
      
     
128. Once daily analgesic tablet
      
     
129. Pharmaceutical excipient having improved compressibility
      
     
130. Dry mix formulation for bisphosphonic acids
      
     
131. Tablet containing an enzymatically converted starch derivative encapsulating agent
      
     
132. Layered tablet for the controlled release of active substances
      
     
133. Direct compression carbonyl iron tablet
      
     
134. Controlled release tablet compositions
      
     
135. Cholesterol-lowering tablets
      
     
136. Use of redispersible polymer powders or polymer granules as binders for producing solid pharmaceutical presentations
      
     
137. Compressed dry-granulation desogestrel tablets
      
     
138. Bioadhesive tablet
      
     
139. Rapid-release S1452 tablets
      
     
140. Preblend of microcrystalline cellulose and lactase for making tablets
      
     
141. Orally administrable solid dosage form
      
     
142. Polymer coated tablet comprising amoxycillin and clavulanate
      
     
143. Fast-dissolving comestible units formed under high-speed/high-pressure condition
      
     
144. Decongestant/antihistaminic compositions
      
     
145. Method and apparatus for preparation of molded tablet and thereby prepared molded tablet
      
     
146. Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
      
     
147. Controlled release tablet of bupropion hydrochloride
      
     
148. Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
      
     
149. Process and apparatus for the production of divisible tablets
      
     
150. Starch products as tabletting excipient, method for preparing same, and method for making tablets
      
     
151. Pharmaceutical compositions containing irbesartan
      
     
152. Cross-linked cellulose as a tablet excipient
      
     
153. Self-binding shearform compositions
      
     
154. Directly compressible high load acetaminophen formulations
      
     
155. Pharmaceutical suspension tablet compositions
      
     
156. Pharmaceutical formulations having improved disintegration and/or absorptivity
      
     
157. Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
      
     
158. Controlled release tablet
      
     
159. Local oral herbal slow release tablets
      
     
160. Method for making fast-melt tablets

Drug Delivery System, Tamper Resistant

1. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
    
2. Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
    
3. Material for controlling diversion of medications
    
4. Tamper-resistant oral opioid agonist formulations

Drug Delivery System, Targeted/Cell-Specific

1. Cardiac targeted delivery of cells
    
2. Targeting of glycoprotein therapeutics
    
3. Targeted therapeutic agent release devices and methods of making and using the same
    
4. Targeted drug-carrying bacteriophages
    
5. Drug delivery to a joint
    
6. Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
    
7. Buoyant polymer particles for delivery of therapeutic agents to the central nervous system
    
8. Membrane active polymers
    
9. Immunoliposomes that optimize internationalization into target cells
    
10. Transporter protein
     
11. Method for in vivo delivery of active compounds using reagent conjugate
     
12. Method for treatment directed to agent retention in biological tissues
     
13. Selective targeting of apoptotic cells
     
14. Methods for delivering compounds into a cell
     
15. Methods for producing target cell reactive lymphocytes
     
16. Delivery carrier for targeting to cells expressed with somatostatin receptors
     
17. Cell penetrating peptides for intracellular delivery of molecules
     
18. Compositions and methods for intracellular delivery of biotinylated cargo
     
19. Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow
     
20. Compounds for targeting hepatocytes
     
21. Compositions and methods for identifying and targeting cancer cells of alimentary canal origin 
     
22. Tissue specific prodrugs
     
23. Compositions and methods of use of targeting peptides against placenta and adipose tissues
     
24. Use of nanoparticles for the DNA administration to a target organ
     
25. Subcellular targeting of therapeutic proteins
     
26. Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
     
27. Induction of a protective immune response through microprojectiles coated with a DNA sequence encoding an immunogenic protein
     
28. Labile linkage for compound delivery to a cell
     
29. Transferring materials into cells using porous silicon
     
30. Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues
     
31. Materials and methods relating to polyions and substance delivery
     
32. Multidrug multiligand conjugates for targeted drug delivery
     
33. Methods and compositions for directing cells to target organs
     
34. Targeting drug/gene carriers to irradiated tissue
     
35. Anti-MUC-1 single chain antibodies for tumor targeting
     
36. Nuclear targeting by means of bacterial proteins
     
37. Enhancement of intracellular delivery and tissue targeting of drugs and genes
     
38. Technology of intracellular delivery of DNA oligonucleotides to improve drug activity
     
39. Systems and methods for delivering drugs to selected locations within the body
     
40. Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
     
41. Method to provide bacterial ghosts provided with antigens

 
42. X-ray guided drug delivery
     
43. Process for generating multilayered particles
     
44. Intracellular delivery of biological effectors
     
45. Drug targeting system, method of its preparation and its use
     
46. Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
     
47. Cellular delivery agent
     
48. Temperature sensitive control of liposome-cell adhesion
     
49. Compositions and methods for tumor-targeted delivery of effector molecules
     
50. Intracellular delivery of biological effectors
     
51. Microprojectile delivery system and particulate product
     
52. Peyer's patch and/or M-cell targeting ligands
     
53. Targeted delivery via biodegradable polymers
     
54. Methods for identifying and isolating tissue-specific lumen-exposed molecules
     
55. Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues
     
56. Chimeric proteins for use in transport of a selected substance into cells
     
57. Enhanced transport using membrane disruptive agents
     
58. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
     
59. VZV ORF29p protein-related compositions and methods
     
60. Polyampholytes for delivering polyions to a cell
     
61. Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
     
62. Sequence and method for genetic engineering of proteins with cell membrane translocating activity
     
63. Method for targeted delivery of nucleic acids
     
64. Transition metal complexes of n, n',n"trialkyl-cis-1,3,5-triaminocyclohexane and related compositions and methods of synthesis and use
     
65. Targeted liposome gene delivery
     
66. Viral recombinant vectors for expression in muscle cellsv
     
67. Antibody/receptor targeting moiety for enhanced delivery of armed ligand
     
68. Drug delivery formulations and targeting
     
69. Method of targeting pharmaceuticals to motor neurons
     
70. Tissue-vectors specific replication and gene expression
     
71. Targeted vectors
     
72. Agents to increase the uptake of pharmaceuticals and diagnostic substances into solid tumors
     
73. Amino acid substitution mutants of interleukin 13
     
74. Materials and methods for intracellular delivery of biologically active molecules
     
75. Molecules that home to various selected organs or tissues
     
76. Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
     
77. Ion exchange tumor targeting (IETT)
     
78. Fibrin nanoparticles and uses thereof
     
79. Cell membrane-directed drugs
     
80. High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
     
81. Method for importing biologically active molecules into cells
     
82. Hybrid compositions for intracellular targeting
     
83. Pharmaceuticals and assays using enzyme subunits
     
84. Covalent microparticle-drug conjugates for biological targeting
     
85. Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
     
86. Genetically modified tumor-targeted bacteria with reduced virulence
     
87. Covalent polar lipid conjugates with neurologically active compounds for targeting
     
88. Non-invasive gene targeting to the brain
    
    
89. Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug
    
    
90. Tumor specific internalizing antigens and methods for targeting therapeutic agents
    
    
91. Conjugate of biologically active compound and polar lipid conjugated to a microparticle for biological targeting
     
    
92. Method of intracellular binding target molecules
     
    
93. Tat-derived transport polypeptides
     
94. Method of identifying molecules that home to a selected organ in vivo
     
    
95. Heart homing peptides and methods of using same
     
    
96. Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen
     
    
97. Delivery of biologically active substance to target sites in the body of patients
     
    
98. Conjugates targeted to the interleukin-2 receptor
     
    
99. Molecules that home to various selected organs or tissues
     
    
100. Cell-specific contrast agent and gene delivery vehicles
      
     
101. Osmotic delivery composition, solution, and method
      
     
102. Immunoliposomes that optimize internalization into target cells
      
     
103. Materials and methods for intracellular delivery of biologically active molecules
      
     
104. Materials and methods for the intracellular delivery of substances
      
     
105. Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells
      
     
106. Targeted polymerized liposome diagnostic and treatment agents
      
     
107. Cell-specific molecule and method for importing DNA into a nucleus
      
     
108. Drug targeting to the nervous system by nanoparticles
      
     
109. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
      
     
110. Receptor ligand-facilitated delivery of biologically active molecules
      
     
111. Site-directed chemotherapy of metastases
      
     
112. Colonic delivery of protein or peptide compositions
      
     
113. DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof
      
     
114. Method of identifying molecules that home to a selected organ in vivo
      
     
115. Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen
      
     
116. Targeted delivery of genes encoding interferon
      
     
117. Drug delivery using terminal complement components
      
     
118. Colon targeted delivery system
      
     
119. Compositions containing nucleic acids and ligands for therapeutic treatment
      
     
120. Targeted delivery of poly- or oligonucleotides to cells
      
     
121. Covalent polar lipid conjugates with neurologically active compounds for targeting
      
     
122. Targeted forms of methyltrithio antitumor agents
      
     
123. Delivery of diagnostic and therapeutic agents to a target site
      
     
124. Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release

Drug Delivery System, Taste Masking/Mouthfeel

1. Taste-masked composition of cationic exchange resin
    
2. Fast dissolving orally consumable films containing a taste masking agent
    
3. Film-shaped or wafer-shaped pharmaceutical preparation with masked taste
    
4. Liquid drug preparations
    
5. Inhibitors of the bitter taste response
    
6. Controlled release and taste masking oral pharmaceutical compositions
    
7. Controlled release and taste masking oral pharmaceutical composition
    
8. Human T2R61 taste receptor and related assays for identifying human bitter taste modulators
    
9. Taste masked veterinary formulation
    
10. Coating compositions for bitterness inhibition
     
11. Pharmaceutical formulation having a masked taste and method for the production thereof
     
12. Particle formation methods and their products
     
13. Ibuprofen composition
     
14. Bitterness-reduced intrabuccally quick disintegrating tablets and method for reducing bitterness
     
15. Particles coated with granulated crystalline ibuprofen
     
16. Nucleotide compounds that block the bitter taste of oral compositions
     
17. Liquid pharmaceutical composition
     
18. Taste masked liquid pharmaceutical compositions
     
19. Taste masked pharmaceutical compositions
     
20. Taste masking rapid release coating system
     
21. Bitterness-reduced oral pharmaceutical composition
     
22. Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract
     
23. Masking agent in powder form for pharmaceutical tastes
     
24. Pediatric formulation of gatifloxacin
     
25. Medicinal compositions with relieved bitterness
     
26. Taste masking coating composition
     
27. Inhibitors of the bitter taste response
     
28. Taste masking of oral quinolone liquid preparations using ion exchange resins
     
29. Pulverulent sorbitol and its process of preparation
     
    
30. Taste-masked pharmaceutical composition
     
    
31. Taste modified hard confectionery compositions containing functional ingredients
     
    
32. Tablets containing a sweetening mixture
     
    
33. Rapidly releasing and taste-masking pharmaceutical dosage form
     
    
34. Granular preparation and producing process thereof
     
    
35. Taste masked liquid suspensions
     
    
36. Flavor blend for masking unpleasant taste of zinc compounds
     
    
37. Dosage forms containing taste masked active agents 
     
    
38. Method and composition for masking mineral taste
     
    
39. Taste-masked formulations
     
    
40. Taste of active pharmaceutical ingredients
     
    
41. Flavor-masked pharmaceutical compositions
     
    
42. Oral compositions having enhanced mouthfeel
     
    
43. Croscarmellose taste masking
     
    
44. Taste masking pharmaceutical composition for oral administration
    
    
45. Taste masking of phenolics using citrus flavors
     
    
46. Taste masked desensitizing compositions

Drug Delivery System,  Teorell-Meyer Gradient

1. Drug dosage form based on the teorell-meyer gradient